Hematologic Oncology | Specialty

The OncLive Hematology Oncology condition center page is a comprehensive resource for clinical news and expert insights on various hematologic malignancies, including leukemias, lymphomas, myeloproliferative neoplasms, multiple myeloma, and much more. This section features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in hematologic cancers.

Maintenance and Frontline Therapy in CLL

January 12th 2018

Managing Patients With CLL

January 12th 2018

Safety and Efficacy of CLL Treatments

January 12th 2018

Therapeutic Approaches for CLL

January 12th 2018

Deciding on CLL Therapy and When to Treat

January 12th 2018

CLL: The Risk of Richter's Transformation

January 12th 2018

The Risk-Stratifying Factors in CLL

January 12th 2018

Expert Highlights RESPONSE Results With Ruxolitinib in Polycythemia Vera

January 11th 2018

Ruben A. Mesa, MD, discusses the significance of the RESPONSE study for patients with polycythemia vera.

Cost Effectiveness and Future of CAR T Therapy

January 9th 2018

Evaluating CAR T-Cell Therapy Use

January 9th 2018

Potential for CAR T-Cell Therapy for R/R AML

January 9th 2018

BCMA-Targeted CAR T-Cell Therapy for Myeloma

January 9th 2018

Allogeneic CAR T-Cell Approaches for NHL

January 9th 2018

The Use of CTL019 in Lymphoma

January 9th 2018

JCAR017 for B-Cell NHL

January 9th 2018

Axi-Cel and Future of CAR T-Cell Therapy in Lymphoma

January 9th 2018

Clinical Data for Axi-Cel in Lymphoma

January 9th 2018

FDA Approval for Axi-Cel in NHL

January 9th 2018

Need for Salvage Therapies in R/R NHL

January 9th 2018

Clinical Data Behind CAR T-Cell Therapies in ALL

January 9th 2018